Literature DB >> 36105431

Neck Circumference is Associated with Metabolic Syndrome Components in Chinese Subjects with Type 2 Diabetes.

Yifei He1, Jin Chen1, Jingzhu Cao1, Yanyan Hu1, Hui Li1, Jin Lu1.   

Abstract

Introduction: We aimed to investigate the correlation between neck circumference (NC) and metabolic syndrome (MetS) components in type 2 diabetes (T2DM) patients.
Methods: This cross-section study included 610 patients with T2DM, including 312 males and 298 females. Height, weight, body mass index (BMI), NC, waist circumference (WC), hip circumference, and blood pressure were measured. Serum glucose, lipid, and uric acid levels were examined. The correlation between NC and anthropometric parameters and metabolic disorders was analyzed. Receiver operating characteristic curve analysis was performed to determine the best NC cutoff value for predicting MetS.
Results: Either in male or female subjects, NC was positively correlated with BMI, WC, waist-to-hip ratio, systolic blood pressure, diastolic blood pressure, and serum triglyceride and uric acid levels and negatively correlated with serum HDL-C levels. NC is an independent influencing factor of female serum uric acid levels (standardized coefficient β = 0.141, t = 2.088, P = 0.038). NC of the MetS group was significantly larger than that of the non-MetS group (male 38.42±3.05 cm vs 36.20±2.90 cm, female 36.14±2.75 cm vs 34.01±2.94 cm, P < 0.001). The NC cutoff value for predicting MetS is 37.3 cm for males and 35.8cm for females. There was no difference between using cutoff points of NC and WC to recognize all MetS components in males and hyperuricemia in females (P>0.05).
Conclusion: NC is closely related to BMI, WC, and MetS components in T2DM. The cutoff points of NC can identify all MetS components in males and hyperuricemia in females with the same efficiency as WC.
© 2022 He et al.

Entities:  

Keywords:  metabolic syndrome; neck circumference; type 2 diabetes

Year:  2022        PMID: 36105431      PMCID: PMC9467291          DOI: 10.2147/DMSO.S379221

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.249


Introduction

Metabolic syndrome (MetS) is a complex metabolic disorder syndrome, mainly manifested by central obesity, dyslipidemia, hypertension, hyperglycemia, and hyperuricemia. These are important risk factors for cardiovascular diseases in diabetic patients.1,2 Anthropometric indicators such as body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR) can be used for the diagnosis of MetS. BMI is a useful index of whole-body adiposity. WC is usually used to indicate the presence of central obesity and visceral fat,3 which is considered as a key component of MetS. However, the measurement of WC may be inconvenient and not accurate with heavy clothing. The measurement of WC may also be influenced by satiety and patient posture. Neck circumference (NC) was first reported by Sjostrom et al in 19954 and seems more convenient for measuring than WC. As an index for upper-body fat distribution, NC is a reliable tool to screen obesity,5 and it has been reported to be positively associated with central obesity and overweight in a range of populations.6–8 Studies have shown that NC is correlated with other anthropometric parameters (eg, WC and BMI), and NC performed well as a tool to identify MetS.9,10 NC was also found to be related to MetS in diabetes.11 In a multicenter prospective study of Chinese type 2 diabetes (T2DM) patients, larger NC was associated with the occurrence of cardiovascular events after 8-year follow-up.12 However, whether NC is associated with single cardiometabolic risk factors correlated with MetS needs to be further studied. The aim of this study was to investigate the correlation between NC and components of MetS in patients with T2DM.

Research Design and Methods

Study Setting and Participants

This cross-section study comprised 610 patients with T2DM who were hospitalized in the Endocrinology Department of Shanghai Changhai Hospital, including 312 males and 298 females. Patients with definite diagnosis of T2DM (following WHO 1999 criteria) were included. Patients were excluded if they were in a stress state such as infection, surgery, malignant tumor, if they were pregnant or breastfeeding, or if they had a history of neck thyroid nodules or neck surgery. The study’s protocol was approved by the ethics committee of Shanghai Changhai Hospital. The following criteria for diagnosing MetS were used.13 Patients who met at least three of the following five items were considered as MetS patients: ① abdominal obesity (WC ≥ 90 cm for males, ≥ 85 cm for females); ② hypertriglyceridemia (triglycerides [TG] ≥ 1.7 mM or having received treatment); ③ low high-density lipoprotein–cholesterol (HDL-C) (HDL-C < 1.04 mM or having received therapy); ④ high blood pressure (Bp) (systolic Bp [SBP] ≥ 130 mmHg, diastolic Bp [DBP] ≥ 85 mmHg, or having received corresponding treatment); and ⑤ hyperglycemia (fasting plasma glucose [FPG] ≥ 6.1 mM, PG ≥ 7.8 mM 2 h after glucose load, or having a history of T2DM).

Data Collection

The medical history of participants was collected. Physical examinations including body weight, height, NC, WC, hip circumference (HC), and Bp were conducted as described below. The patients stood upright and faced the researchers with their shoulders relaxed. NC was measured at the horizontal circumference of the neck through the lower border of the Adam’s apple, WC was measured at the midpoint of the line connecting the coastal border and the iliac spine after the patient exhaled calmly, and HC was measured at the greater trochanter. Bp was measured three times continuously after 10 min of rest, and the average value was taken. BMI was calculated as (weight [kg]/height2 [m2]) and WHR was calculated as (WC/HC).

Laboratory Assessments

Laboratory data were measured from blood, which was taken in the morning after an overnight fast of at least 10 h. Serum glucose and uric acid levels and the lipid profile, including total cholesterol (TC), TG, HDL-C, and LDL-C, were determined on a HITACHI 7600–120 automatic biochemical analyzer (Hitachi Co., Japan).

Statistical Analyses

All analyses were performed using SPSS 22.0 statistical software. Continuous variables are expressed as mean ± standard deviation (X±S), and the independent-samples t-test was used for comparison. Categorical variables are expressed as percentages, and χ2 analysis was used to compare differences between groups. Pearson’s correlation coefficient was used to evaluate the relationship between NC and MetS risks. Multiple linear regression was used to analyze the factors independently affected by NC. The best NC cutoff value to predict MetS was estimated by using Youden’s index and receiver operating characteristic (ROC) analyses. P<0.05 was used for statistical significance.

Results

This study included 610 participants: 312 males with a mean age of 58.45±13.23 years, a mean BMI of 23.84±3.23 kg/m2, and a mean WC of 90.14±11.19 cm and 298 females with a mean age of 62.66±12.06 years, a mean BMI of 24.79±4.13 kg/m2, and a mean WC of 90.96±12.88 cm, as shown in

Correlation Between NC and Anthropometric Parameters and MetS Components

As shown in Table 1, in both male and female subjects, NC was positively correlated with BMI, WC, and WHR. And NC is linearly related to WC in both male and female subjects, as shown in . As shown in Table 2, NC was positively correlated with SBP, DBP, serum TG, and uric acid levels in both males and females and negatively correlated with serum HDL-C levels in both males and females.
Table 1

Correlation of Neck Circumference with Anthropometric Parameters

Neck Circumference
Males (n=312)Females (n=298)All (n=610)
rPrPrP
BMI0.575<0.0010.661<0.0010.530<0.001
WC0.464<0.0010.604<0.0010.489<0.001
WHR0.380<0.0010.368<0.0010.373<0.001

Abbreviations: r, Pearson’s correlation coefficient; BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio.

Table 2

Correlation of Neck Circumference with Metabolic Variables

Neck Circumference
Males (n=312)Females (n=298)All (n=610)
rPrPrP
SBP0.1190.0350.1650.0040.1110.006
DBP0.1610.0040.220<0.0010.185<0.001
TG0.1780.0020.1310.0240.1200.003
TC0.0360.5310.0110.853−0.0330.410
HDL-C−0.1250.027−0.140.015−0.18<0.001
LDL-C0.0310.5890.0020.979−0.020.616
HbA1c−0.0050.927−0.0740.191−0.0430.284
UA0.1770.0020.261<0.0010.240<0.001

Abbreviations: r, Pearson’s correlation coefficient; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; UA, uric acid.

Correlation of Neck Circumference with Anthropometric Parameters Abbreviations: r, Pearson’s correlation coefficient; BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio. Correlation of Neck Circumference with Metabolic Variables Abbreviations: r, Pearson’s correlation coefficient; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; UA, uric acid. Multiple linear regression analysis showed that after adjusting for age, duration of diabetes, serum glucose, Bp, serum lipids, and other factors, NC had an independent effect on female serum uric acid levels (standardized coefficient β = 0.141, t = 2.088, P = 0.038); however, there was no independent correlation between WC and female serum uric acid levels (standardized coefficient β = 0.096, t = 1.430, P = 0.154).

Comparison of Neck Circumference in MetS and Non-MetS Groups

Subjects were divided into MetS (n=397) and non-MetS (n=213) groups. As shown in , there was no difference of gender, diabetic duration and HbA1c level between the MetS and non-MetS groups. As shown in Table 3, in both male and female subjects, NC was significantly larger in in MetS group than in the non-MetS group (male 38.42±3.05 cm vs 36.20±2.90 cm, female 36.14±2.75 cm vs 34.01±2.94 cm, P < 0.001).
Table 3

Comparison of NC Between MetS Group and Non-MetS Group

MetS (n=397)Non-MetS (n=213)P value
Male NC (cm)38.42±3.0536.20±2.90<0.001
Female NC (cm)36.14±2.7534.01±2.94<0.001
All subjects NC (cm)37.29±3.1635.15±3.11<0.001

Abbreviations: NC, neck circumference; MetS, metabolic syndrome.

Comparison of NC Between MetS Group and Non-MetS Group Abbreviations: NC, neck circumference; MetS, metabolic syndrome. The areas under the ROC curves (AUCs) were calculated to evaluate the predictive values of NC for MetS (Figure 1). The AUCs of NC were 0.701 (95% confidence interval [CI], 0.643–0.760) for males and 0.707 (95% CI, 0.641–0.773) for females. Youden index was calculated and NC ≥ 37.3 cm (sensitivity 0.662, specificity 0.649) for males and NC ≥ 35.8 cm (sensitivity 0.59, specificity 0.67) for females was considered as the best cutoff values in identifying MetS.
Figure 1

Receiver operating characteristic (ROC) curves of neck circumference for identifying metabolic syndrome in Males and Females. The areas under the ROC curves (AUCs) were calculated to evaluate the predictive values of NC for MetS. The AUCs of NC were 0.701 (95% confidence interval [CI], 0.643–0.760) for males and 0.707 (95% CI, 0.641–0.773) for females. Youden index was calculated and NC ≥ 37.3 cm (sensitivity 0.662, specificity 0.649) for males and NC ≥ 35.8 cm (sensitivity 0.59, specificity 0.67) for females was considered as the best cutoff values in identifying MetS.

Receiver operating characteristic (ROC) curves of neck circumference for identifying metabolic syndrome in Males and Females. The areas under the ROC curves (AUCs) were calculated to evaluate the predictive values of NC for MetS. The AUCs of NC were 0.701 (95% confidence interval [CI], 0.643–0.760) for males and 0.707 (95% CI, 0.641–0.773) for females. Youden index was calculated and NC ≥ 37.3 cm (sensitivity 0.662, specificity 0.649) for males and NC ≥ 35.8 cm (sensitivity 0.59, specificity 0.67) for females was considered as the best cutoff values in identifying MetS.

Identification of MetS Components by NC or WC

As shown in Table 4, there was no difference between using cutoff points of NC (≥ 37.3 cm) and WC (≥ 90 cm) to recognize MetS components in males, which include high Bp (SBP ≥ 130 mmHg or DBP ≥ 85 mmHg), hypertriglyceridemia (TG ≥ 1.7 mM), low HDL-C (HDL-C < 1.04 mM) and hyperuricemia (uric acid ≥ 420 nM). in males, in females). However, in females, there was no difference between using cutoff points of NC (≥ 35.8 cm) and WC (≥ 85 cm) only when identifying hyperuricemia (uric acid ≥ 360 nM). In females diagnosed with high Bp, hypertriglyceridemia and low HDL-C, the recognition rate of NC ≥ 35.8 cm was lower than that of WC ≥ 85 cm, seen in Table 4. It is suggested that this cutoff point of NC can identify MetS components with the same efficiency as WC in males, but only in female hyperuricemia.
Table 4

Identification Rate of MetS Components by NC and WC*

MalesFemales
NCWCP valueNCWCP value
High SBP59.43%54.29%0.33155.90%74.87%0.000
High DBP65.63%60.42%0.45555.84%76.62%0.006
Hypertriglyceridemia71.74%77.17%0.39860.00%80.95%0.002
Low HDL-C59.86%57.82%0.72254.17%69.44%0.059
Hyperuricemia63.16%76.32%0.21266.04%79%0.127

Note: *Using NC cut-off point (male≥37.3cm, female≥35.8cm) and WC cut-off point (male≥90cm, female≥85cm) to recognize disorders.

Abbreviations: High SBP, SBP≥130mmHg; High DBP, DBP≥85mmHg; Hypertriglyceridemia, TG≥ 1.7mmol/L; Low HDL-C, HDL-C<1.04mmol/L; Hyperuricemia, uric acid≥420nmol/L in males and≥ 360 nmol/L in females.

Identification Rate of MetS Components by NC and WC* Note: *Using NC cut-off point (male≥37.3cm, female≥35.8cm) and WC cut-off point (male≥90cm, female≥85cm) to recognize disorders. Abbreviations: High SBP, SBP≥130mmHg; High DBP, DBP≥85mmHg; Hypertriglyceridemia, TG≥ 1.7mmol/L; Low HDL-C, HDL-C<1.04mmol/L; Hyperuricemia, uric acid≥420nmol/L in males and≥ 360 nmol/L in females.

Discussion

In this research, we found that NC was positively correlated with anthropometric parameters (BMI, WC, and WHR) and MetS components (SBP, DBP, TG and uric acid) in patients with T2DM, while it was negatively correlated with serum HDL-C levels. After adjusting for multiple interference factors, NC was an independent factor associated with serum uric acid levels in females. We also estimated the optimal cut-off value of NC to predict the risk of MetS and found that the estimated value of NC was significantly associated with MetS components in T2DM. With the improvement of living standards, the incidence rate of MetS is increasing. Obesity, especially abdominal obesity, plays an important role in MetS. Vague et al reported that when the physical shape and fat distribution type of obese individuals are different, the health risks to the body are also different.14 Studies suggest that fat of the upper body releases more free fatty acids (FFAs) than that of the lower body.15 The increase in FFA levels can seriously interfere with the signal transduction pathway of insulin and hence cause or aggravate insulin resistance. Therefore, compared with lower body obesity, upper body obesity is more likely to lead to MetS, including impaired glucose tolerance, hyperinsulinemia, hyperlipidemia, and hyperuricemia.16 Upper body subcutaneous fat is positively correlated with MetS and is an independent risk factor for MetS. A simple and easy measurement index of upper body obesity is of great significance to MetS epidemiology. At present, WC is an internationally recognized diagnostic index of central obesity, but the body surface mark to measure WC is not obvious, it is inconvenient to measure in winter, and it is easily disturbed by factors such as a full stomach and recent exercise. As one of the evaluation indexes of upper body adipose, the measurement of NC is relatively convenient and simple. NC is highly correlated with traditional anthropometric indicators such as WC, BMI, WHR, especially WC.11 NC was shown to be positively correlated with central obesity and with visceral fat accumulation17,18 by computed tomography and magnetic resonance imaging. Li et al19 found that neck adipose area was correlated with abdominal visceral adipose tissue (VAT) area significantly in men (r = 0.57) and women (r = 0.53). They considered NC can be used as an indicator for evaluating central obesity and MetS. Some studies even showed that NC can better evaluate metabolic health than WC.20,21 ROC analyses showed that NC was better in distinguishing T2DM, insulin resistance, MetS, and hypertension in individuals with severe obesity.21 NC was an independent predictor for fatty liver disease and provided an additional contribution when applied with other anthropometric measures.22 Compared with BMI and WC, NC alone can improve the prediction of cardiovascular disease risk factors.23,24 Research suggests that in males and females, an NC of 37 and 34 cm, respectively, is equivalent to a BMI of 25.0 kg/m2, and an NC of 39.5 and 36.5 cm, respectively, is equivalent to a BMI of 30.0 kg/m2.5 NC can be used as a new anthropometric index to help judge MetS and metabolic indexes. The NC cutoff value is a good predictor of MetS and associated diseases. However, the NC cutoff values for identifying MetS and obesity differed due to region,25 age,26 medical history,11 etc. A previous study suggested that NC ≥ 38 cm for males and NC ≥ 33 cm for females are the optimal cutoff values for predicting MetS in a Thai population.25 A survey of 3182 Chinese patients with T2DM showed that NC ≥ 39 cm in males and NC > 35 cm in females was the best cutoff value for the classification of MetS in this population.11 In an elder population, an analysis of 2092 individuals aged over 65 years suggested that NC ≥38 cm for males and ≥35 cm for females was the best cutoff value for diagnosing MS.26 According to the diagnostic criteria of MetS proposed by the International Diabetes Federation (IDF) in 2005, WC ≥ 90 cm in males and WC ≥ 80 cm in females were defined as central obesity, and the optimal NC cutoff value corresponding to this WC was 38.5 cm in males and 34.5 cm in females.1 In our study, the population we selected was diabetic patients in the middle-elderly population. The optimal NC cutoff value in predicting MetS was 37.3 cm in males and 35.8 cm in females. The results are similar to those of other studies. This NC cutoff value could be used to identify male all MetS components such as high Bp, hypertriglyceridemia, low HDL-C, hyperuricemia and female hyperuricemia with the same efficiency as WC in our study. There are some limitations in our study. First, the sample size of the study was relatively small. Second, the subjects are all patients with T2DM, further studies are needed to identify the relationship of NC with MetS in general population. Thirdly, the female NC cutoff value in our study was higher than that in other studies, which may be one of the reasons why the recognition rates of some female MetS components were lower than that of WC. Therefore, further statistical analysis of large samples is needed. In conclusion, NC and WC have comparable associations with the components of MetS in Chinese T2DM. NC is expected to be an easy upper body surface measurement for predicting MetS and its components, especially in males and female hyperuricemia.
  26 in total

Review 1.  Anthropometric indicators of insulin resistance.

Authors:  Ana Carolina Vasques; Lina Rosado; Gilberto Rosado; Rita de Cassia Ribeiro; Sylvia Franceschini; Bruno Geloneze
Journal:  Arq Bras Cardiol       Date:  2010-07       Impact factor: 2.000

2.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. 1956.

Authors:  J Vague
Journal:  Nutrition       Date:  1999-01       Impact factor: 4.008

3.  Neck circumference as a predictor of metabolic syndrome: A cross-sectional study.

Authors:  Issarayus Laohabut; Kamol Udol; Pochamana Phisalprapa; Weerachai Srivanichakorn; Thanet Chaisathaphol; Chaiwat Washirasaksiri; Tullaya Sitasuwan; Charoen Chouriyagune; Chonticha Auesomwang
Journal:  Prim Care Diabetes       Date:  2019-09-14       Impact factor: 2.459

Review 4.  Lipolysis: contribution from regional fat.

Authors:  M D Jensen
Journal:  Annu Rev Nutr       Date:  1997       Impact factor: 11.848

5.  Fat distribution and health in obesity.

Authors:  J B Albu; A J Kovera; J A Johnson
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

6.  Body compartment and subcutaneous adipose tissue distribution--risk factor patterns in obese subjects.

Authors:  C D Sjöström; A C Håkangård; L Lissner; L Sjöström
Journal:  Obes Res       Date:  1995-01

7.  Neck circumference as a new anthropometric indicator for prediction of insulin resistance and components of metabolic syndrome in adolescents: Brazilian Metabolic Syndrome Study.

Authors:  Cleliani de Cassia da Silva; Mariana Porto Zambon; Ana Carolina J Vasques; Ana Maria de B Rodrigues; Daniella Fernandes Camilo; Maria Ângela R de G M Antonio; Roberta Soares L Cassani; Bruno Geloneze
Journal:  Rev Paul Pediatr       Date:  2014-06

8.  Neck Circumference as an Anthropometric Indicator of Central Obesity in Patients with Prediabetes: A Cross-Sectional Study.

Authors:  Thunyarat Anothaisintawee; Nakarin Sansanayudh; Sangsulee Thamakaison; Dumrongrat Lertrattananon; Ammarin Thakkinstian
Journal:  Biomed Res Int       Date:  2019-06-09       Impact factor: 3.411

9.  Neck circumference and waist circumference associated with cardiovascular events in type 2 diabetes (Beijing Community Diabetes Study 23).

Authors:  Guang-Ran Yang; Ming-Xia Yuan; Gang Wan; Xue-Lian Zhang; Han-Jing Fu; Shen-Yuan Yuan; Liang-Xiang Zhu; Rong-Rong Xie; Jian-Dong Zhang; Yu-Ling Li; Yan-Hua Sun; Qin-Fang Dai; Da-Yong Gao; Xue-Li Cui; Jian-Qin Gao; Zi-Ming Wang; Ying-Jun Chen; Yong-Jin Li; Dong-Ming Hu; Juan Gao; Ying Gao; Jie Miao; Yu-Jie Chen; Rury R Holman
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

10.  Neck circumference as a measure of neck fat and abdominal visceral fat in Chinese adults.

Authors:  Hong-Xing Li; Fen Zhang; Dong Zhao; Zhong Xin; Shu-Qin Guo; Shu-Mei Wang; Jian-Jun Zhang; Jun Wang; Yan Li; Guang-Ran Yang; Jin-Kui Yang
Journal:  BMC Public Health       Date:  2014-04-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.